124 related articles for article (PubMed ID: 15117442)
1. Limitations of 17-hydroxyprogesterone in investigating neonatal hyponatraemia.
Ismail AA; Cawood M; Ufodiama EB; Jones ST
Ann Clin Biochem; 2004 May; 41(Pt 3):245-7. PubMed ID: 15117442
[TBL] [Abstract][Full Text] [Related]
2. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
Mitchell ML; Hermos RJ
Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565
[TBL] [Abstract][Full Text] [Related]
3. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
[TBL] [Abstract][Full Text] [Related]
4. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
Santos CM; Abad LR; Cua SC; Domingo CF
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
Varness TS; Allen DB; Hoffman GL
J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
[TBL] [Abstract][Full Text] [Related]
6. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
8. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
Gu X; Zhou J; Ye J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
[TBL] [Abstract][Full Text] [Related]
9. [About a case of congenital hypothyroidism].
d'Almeida M; Georges A; Bordenave L; Corcuff JB
Ann Biol Clin (Paris); 2007; 65(5):539-43. PubMed ID: 17913673
[TBL] [Abstract][Full Text] [Related]
10. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
[TBL] [Abstract][Full Text] [Related]
11. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
[TBL] [Abstract][Full Text] [Related]
12. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
Fingerhut R
Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
[TBL] [Abstract][Full Text] [Related]
13. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
[TBL] [Abstract][Full Text] [Related]
14. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW
Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
[TBL] [Abstract][Full Text] [Related]
15. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency.
Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247
[TBL] [Abstract][Full Text] [Related]
16. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
17. Postnatal virilization mimicking 21-hydroxylase deficiency in 3 very premature infants.
Couch R; Girgis R
Pediatrics; 2012 May; 129(5):e1364-7. PubMed ID: 22473363
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of 17-OH-progesterone (OHPG) for diagnosis of congenital adrenal hyperplasia (CAH).
Singh RJ
Methods Mol Biol; 2010; 603():271-7. PubMed ID: 20077078
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
Kao PC; Machacek DA; Magera MJ; Lacey JM; Rinaldo P
Ann Clin Lab Sci; 2001 Apr; 31(2):199-204. PubMed ID: 11337910
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of adrenocortical tumor in a neonate by detection of elevated blood 17-hydroxyprogesterone measured as a routine neonatal screening for congenital adrenal hyperplasia: a case report.
Hishiki T; Kazukawa I; Saito T; Terui K; Mitsunaga T; Nakata M; Matsuura G; Minagawa M; Kohno Y; Yoshida H
J Pediatr Surg; 2008 Oct; 43(10):e19-22. PubMed ID: 18926198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
